Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Department of the Treasury
Fierce Biotech
Will COINS Act kill China biotech licensing boom?
Amid China’s rapid biotech ascent, a growing chorus in the U.S. wants biotechnology added to the COINS Act to restrict outbound capital flows.
Angus Liu
May 26, 2026 3:50pm
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit
Sep 14, 2021 4:00pm
AbbVie, Shire investors settle lawsuit over scuttled merger
Apr 12, 2019 11:50am
Brace yourself, pharma: Tax inversions could return
Apr 24, 2017 11:22am
